NIH-funded research R01 grant

Enhanced MRI to detect brain metastases

Official title: Improved Detection of Cerebral Metastases using a using a Novel T1 Relaxation-Enhanced Steady-State (T1RESS) MRI Technique

Funded at Endeavor Health Clinical Operations · NIH-11370115 · Data updated 2026-11-12

This project uses a new contrast MRI method to make very small brain metastases and leptomeningeal disease easier to see in adults with cancer.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionEndeavor Health Clinical Operations
NIH-funded
Lab location1 site (Evanston, United States)
Project startApril 12, 2022
Project endMarch 31, 2027
Funding year2026
Award (this year)$452,681
NIH project number5R01CA263091-05
Project IDNIH-11370115 on NIH RePORTER

Who could benefit from this research

Could help

Adults age 21 or older with known or suspected brain metastases or cancer at high risk for brain spread who can undergo contrast-enhanced MRI are the best candidates.

Less likely to help

People who cannot have MRI (for example because of incompatible implants), cannot receive MRI contrast (severe kidney problems), or who do not have suspicion of brain metastases are unlikely to benefit.

What this research studies

You would receive a contrast-enhanced MRI that uses a new pulse sequence called uT1RESS designed to make tumors stand out from normal brain and to darken blood vessels. The researchers will compare these images with standard MRI scans (like MPRAGE) to see if the new method finds more small metastases or leptomeningeal spread. The team has already published encouraging results from 54 adult patients and will expand and refine the imaging approach in a larger patient group. The imaging protocol is done at the study site and focuses on improving how clearly tiny or hard-to-see lesions appear.

Why it matters

Potential benefit: If successful, this could help doctors find smaller or hidden brain metastases earlier, improving treatment choices such as radiosurgery or targeted therapies.

How similar studies have gone: A preliminary study of 54 adult patients published in Science Advances showed a twofold or greater improvement in tumor-to-brain contrast, indicating strong early promise though larger validation is needed.

Where this research is happening

  • Endeavor Health Clinical Operations
    Evanston, United States
    Active

Researchers

  • Principal investigator: Edelman, Robert R. — Endeavor Health Clinical Operations
  • Study coordinator: Edelman, Robert R.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.